Skip to main content

West Pharmaceutical Services Inc

WST
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000105770

In the last 90 days, West Pharmaceutical Services Inc insiders filed 0 open-market purchases and 2 sales; 834 institutions reported holding it in 13F filings for Q2 2026, worth $25.2B in total; Gates Foundation Trust is the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in West Pharmaceutical Services Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
718
−7 vs. Q4 2021
Shares held
70.6M
+1.19M (+1.7%) vs. Q4 2021
Total value
$28.2B
−$3.90B (−12.1%) vs. Q4 2021
New holders
75
246 more added
Sold out
82
277 more reduced

6 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting WST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 718 institutions
Q1 2021: 591 institutionsQ2 2021: 641 institutionsQ3 2021: 672 institutionsQ4 2021: 731 institutionsQ1 2022: 718 institutionsQ2 2022: 657 institutionsQ3 2022: 638 institutionsQ4 2022: 638 institutionsQ1 2023: 698 institutionsQ2 2023: 735 institutionsQ3 2023: 759 institutionsQ4 2023: 784 institutionsQ1 2024: 778 institutionsQ2 2024: 778 institutionsQ3 2024: 733 institutionsQ4 2024: 747 institutionsQ1 2025: 715 institutionsQ2 2025: 733 institutionsQ3 2025: 758 institutionsQ4 2025: 804 institutionsQ1 2026: 755 institutionsQ2 2026: 834 institutions
Value heldQ1 2022: $28.2B
Q1 2021: $19.3BQ2 2021: $24.7BQ3 2021: $28.5BQ4 2021: $32.2BQ1 2022: $28.2BQ2 2022: $20.6BQ3 2022: $16.9BQ4 2022: $16.3BQ1 2023: $24.0BQ2 2023: $26.0BQ3 2023: $25.8BQ4 2023: $24.1BQ1 2024: $27.0BQ2 2024: $22.4BQ3 2024: $20.5BQ4 2024: $22.9BQ1 2025: $15.6BQ2 2025: $15.3BQ3 2025: $18.0BQ4 2025: $19.1BQ1 2026: $17.8BQ2 2026: $25.2B
Institutions holding WST and their total value by quarter
QuarterHoldersValue
Q2 2026834$25.2B
Q1 2026755$17.8B
Q4 2025804$19.1B
Q3 2025758$18.0B
Q2 2025733$15.3B
Q1 2025715$15.6B
Q4 2024747$22.9B
Q3 2024733$20.5B
Q2 2024778$22.4B
Q1 2024778$27.0B
Q4 2023784$24.1B
Q3 2023759$25.8B
Q2 2023735$26.0B
Q1 2023698$24.0B
Q4 2022638$16.3B
Q3 2022638$16.9B
Q2 2022657$20.6B
Q1 2022718$28.2B
Q4 2021731$32.2B
Q3 2021672$28.5B
Q2 2021641$24.7B
Q1 2021591$19.3B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding West Pharmaceutical Services Inc; share changes are against Q4 2021.

Institutions holding WST in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Andra AP-fonden––––Not filed
MD Financial Management Inc.––––Not filed
NEXT Financial Group, Inc––––Not filed
Carroll Financial Associates, Inc.––––Not filed
Bell Investment Advisors, Inc––––Not filed
Harbour Investments, Inc.––––Not filed